Key facts
- This page summarizes Laith L. Yaldoo's Form 4 filing for Zivo Bioscience, Inc. (ZIVO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2026, 16:06.
Laith L. Yaldoo - 27 Feb 2026 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- ZIVO
- Reported as of
- 27 Feb 2026
- Net transaction value
- +$14,998
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 16:06:40 UTC
- Prior SEC filing
- 12 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Laith L. Yaldoo
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Laith L. Yaldoo filed Form 4 for Zivo Bioscience, Inc. (ZIVO) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 12 Feb 2026.
- Current net transaction value: +$14,998.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001641073
Primary reporting owner
YALDOO LAITH L
- Relationship
- Director, 10%+ Owner
- Address
- 1934 BLOOMFIELD DRIVE, BLOOMFIELD HILLS
- Signature
- /s/ Laith L. Yaldoo
- Signature date
- 03 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZIVO
transaction
Common Stock
Purchase
- Transaction value
- $14,998
- Shares
- +1,543
- Change %
- +0.27%
- Price
- $9.72
- Shares after
- 583,615
- Date
- 27 Feb 2026
- Ownership
- HEP Investment, LLC
* marks a reported price that did not pass the local price check.